Search

Maury A. Audet

Examiner (ID: 761)

Most Active Art Unit
1654
Art Unit(s)
1654, 1675, 1658
Total Applications
1576
Issued Applications
696
Pending Applications
264
Abandoned Applications
656

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17140214 [patent_doc_number] => 20210308225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => Long-Acting Formulations of Insulin [patent_app_type] => utility [patent_app_number] => 17/176442 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176442 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176442
Long-Acting Formulations of Insulin Feb 15, 2021 Abandoned
Array ( [id] => 19624155 [patent_doc_number] => 12162959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-10 [patent_title] => Cyclic peptide for treating cancer [patent_app_type] => utility [patent_app_number] => 17/176983 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 4830 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176983 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176983
Cyclic peptide for treating cancer Feb 15, 2021 Issued
Array ( [id] => 16977629 [patent_doc_number] => 20210221866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => PROTEASE-RESISTANT LIPIDATED GLP-1 ANALOGS [patent_app_type] => utility [patent_app_number] => 17/169833 [patent_app_country] => US [patent_app_date] => 2021-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23487 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169833 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/169833
PROTEASE-RESISTANT LIPIDATED GLP-1 ANALOGS Feb 7, 2021 Abandoned
Array ( [id] => 16855173 [patent_doc_number] => 20210155918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => RECOMBINANT PROTHROMBIN ANALOGUES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/157130 [patent_app_country] => US [patent_app_date] => 2021-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14175 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17157130 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/157130
Recombinant prothrombin analogues and uses thereof Jan 24, 2021 Issued
Array ( [id] => 17096894 [patent_doc_number] => 20210284685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => METHODS FOR REMOVING A CONTAMINANT USING INDIGENOUS PROTEIN DISPLACEMENT ION EXCHANGE MEMBRANE CHROMATOGRAPHY [patent_app_type] => utility [patent_app_number] => 17/153826 [patent_app_country] => US [patent_app_date] => 2021-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153826 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/153826
METHODS FOR REMOVING A CONTAMINANT USING INDIGENOUS PROTEIN DISPLACEMENT ION EXCHANGE MEMBRANE CHROMATOGRAPHY Jan 19, 2021 Pending
Array ( [id] => 16839565 [patent_doc_number] => 20210147577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => Mutated Immunoglobulin-Binding Polypeptides [patent_app_type] => utility [patent_app_number] => 17/149830 [patent_app_country] => US [patent_app_date] => 2021-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17149830 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/149830
Mutated immunoglobulin-binding polypeptides Jan 14, 2021 Issued
Array ( [id] => 16807845 [patent_doc_number] => 20210130398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => PROTEIN PURIFICATION [patent_app_type] => utility [patent_app_number] => 17/145231 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13602 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145231 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/145231
PROTEIN PURIFICATION Jan 7, 2021 Abandoned
Array ( [id] => 16885376 [patent_doc_number] => 20210171571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => PROTEIN PURIFICATION [patent_app_type] => utility [patent_app_number] => 17/145235 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13638 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145235 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/145235
PROTEIN PURIFICATION Jan 7, 2021 Abandoned
Array ( [id] => 16807846 [patent_doc_number] => 20210130399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => PROTEIN PURIFICATION [patent_app_type] => utility [patent_app_number] => 17/145233 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145233 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/145233
PROTEIN PURIFICATION Jan 7, 2021 Abandoned
Array ( [id] => 16948144 [patent_doc_number] => 20210206835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => Self-Assembling Collagen-Like Polypeptides for Applications and Uses Related Thereto [patent_app_type] => utility [patent_app_number] => 17/140449 [patent_app_country] => US [patent_app_date] => 2021-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7390 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140449 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/140449
Self-assembling collagen-like polypeptides for applications and uses related thereto Jan 3, 2021 Issued
Array ( [id] => 16915837 [patent_doc_number] => 20210188929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => Peptides and Nanoparticle Formulations Thereof [patent_app_type] => utility [patent_app_number] => 17/134977 [patent_app_country] => US [patent_app_date] => 2020-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16601 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17134977 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/134977
Peptides and nanoparticle formulations thereof Dec 27, 2020 Issued
Array ( [id] => 18575499 [patent_doc_number] => 11732013 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-22 [patent_title] => Astexin peptides [patent_app_type] => utility [patent_app_number] => 17/128632 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 20572 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128632 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/128632
Astexin peptides Dec 20, 2020 Issued
Array ( [id] => 16748763 [patent_doc_number] => 20210100772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => METHODS FOR TREATING ALOPECIA AND ACHROMOTRICHIA [patent_app_type] => utility [patent_app_number] => 17/124572 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7658 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124572 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/124572
METHODS FOR TREATING ALOPECIA AND ACHROMOTRICHIA Dec 16, 2020 Abandoned
Array ( [id] => 16824256 [patent_doc_number] => 20210139549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY, CLEAVABLE PORTION, AND REACTIVE GROUP, OR SALT THEREOF [patent_app_type] => utility [patent_app_number] => 17/119786 [patent_app_country] => US [patent_app_date] => 2020-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 127867 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 445 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119786 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/119786
COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY, CLEAVABLE PORTION, AND REACTIVE GROUP, OR SALT THEREOF Dec 10, 2020 Pending
Array ( [id] => 16824248 [patent_doc_number] => 20210139541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY AND BIOORTHOGONAL FUNCTIONAL GROUP, OR SALT THEREOF [patent_app_type] => utility [patent_app_number] => 17/119495 [patent_app_country] => US [patent_app_date] => 2020-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62713 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119495 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/119495
COMPOUND HAVING AFFINITY SUBSTANCE TO ANTIBODY AND BIOORTHOGONAL FUNCTIONAL GROUP, OR SALT THEREOF Dec 10, 2020 Pending
Array ( [id] => 19256872 [patent_doc_number] => 12016901 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Tissue catalyzed growth of polymer as epithelial linings for therapy [patent_app_type] => utility [patent_app_number] => 17/118521 [patent_app_country] => US [patent_app_date] => 2020-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 101 [patent_no_of_words] => 30315 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118521 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/118521
Tissue catalyzed growth of polymer as epithelial linings for therapy Dec 9, 2020 Issued
Array ( [id] => 16762358 [patent_doc_number] => 20210107939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => ANTIMICROBIAL COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/116054 [patent_app_country] => US [patent_app_date] => 2020-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11508 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116054 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/116054
Antimicrobial compounds Dec 8, 2020 Issued
Array ( [id] => 17641941 [patent_doc_number] => 20220169679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => NOVEL ANGIOTENSIN I-CONVERTING ENZYME (ACE) INHIBITORY PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/109056 [patent_app_country] => US [patent_app_date] => 2020-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6540 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109056 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/109056
Angiotensin I-converting enzyme (ACE) inhibitory peptides Nov 30, 2020 Issued
Array ( [id] => 16710443 [patent_doc_number] => 20210077590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => METHOD FOR PREVENTING OR TREATING OSTEOPOROSIS, CHARACTERIZED BY ADMINISTERING TERIPARATIDE OR SALT THEREOF AT A FREQUENCY OF TWICE A WEEK [patent_app_type] => utility [patent_app_number] => 17/104734 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104734 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/104734
METHOD FOR PREVENTING OR TREATING OSTEOPOROSIS, CHARACTERIZED BY ADMINISTERING TERIPARATIDE OR SALT THEREOF AT A FREQUENCY OF TWICE A WEEK Nov 24, 2020 Abandoned
Array ( [id] => 16868533 [patent_doc_number] => 20210162000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/095992 [patent_app_country] => US [patent_app_date] => 2020-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26794 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17095992 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/095992
PCSK9 inhibitory polypolypeptides and methods of use Nov 11, 2020 Issued
Menu